Lilly Targets Aduhelm With Aggressive Plans For Donanemab In Alzheimer’s

 
• By Joseph Haas
  
target
Lilly has Biogen in its sights for Alzheimer's disease competition • Source: Alamy (hoch2wo / Alamy Stock Photo/Alamy Stock Photo)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business